Momentum seems to be building behind biotech financings as the first month of 2023 draws to a close, with a respectable raise for cancer startup Synnovation Therapeutics and Adicet Bio, Calluna Pharma, Accent Therapeutics, GenEdit and IMU Bio also in on the action.
